Ondine Biomedical (FRA:VF5) OCF Margin %: -837.19% (As of Dec. 2025)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
37 GF Score
Price €0.15
GF Value €0.09
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Ondine Biomedical OCF Margin %?

Ondine Biomedical FRA:VF5 37 OCF Margin % is -837.19% as of Dec. 2025. GuruFocus rates FRA:VF5 with a GF Score™ of 37/100 and a GF Value™ of €0.09 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 950 Biotechnology companies, Ondine Biomedical ranks worse than 79.26% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Ondine Biomedical's Cash Flow from Operations for the six months ended in Dec. 2025 was €-8.46 Mil. Ondine Biomedical's Revenue for the six months ended in Dec. 2025 was €1.01 Mil. Therefore, Ondine Biomedical's OCF Margin % for the quarter that ended in Dec. 2025 was -837.19%.

As of today, Ondine Biomedical's current OCF Yield % is -17.11%.

The historical rank and industry rank for Ondine Biomedical's OCF Margin % or its related term are showing as below:

FRA:VF5' s OCF Margin % Range Over the Past 10 Years
Min: -2707.31   Med: -1018.36   Max: -177.44
Current: -901.93

During the past 13 years, the highest OCF Margin % of Ondine Biomedical was -177.44%. The lowest was -2707.31%. And the median was -1018.36%.

FRA:VF5's OCF Margin % is ranked worse than
79.26% of 950 companies
in the Biotechnology industry
Industry Median: -65.71 vs FRA:VF5: -901.93

Ondine Biomedical OCF Margin % Related Terms

Ondine Biomedical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical OCF Margin % Chart

Ondine Biomedical Annual Data
Trend Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -488.18 -2,563.88 -1,135.28 -756.23 -901.28

Ondine Biomedical Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -706.60 -825.09 -706.14 -1,003.73 -837.19

FRA:VF5 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Ondine Biomedical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's OCF Margin % falls into.


FRA:VF5
37GF Score
Ondine Biomedical Inc FRA:VF5
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Ondine Biomedical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-14.763/1.638
=-901.28 %

Ondine Biomedical's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-8.464/1.011
=-837.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -837.19% mean?
Ondine Biomedical (FRA:VF5) has a OCF Margin % of -837.19% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ondine Biomedical and its competitors. According to the industry distribution chart, Ondine Biomedical ranks #753 out of 950 companies in the Biotechnology industry, placing it in the top 79.3%.
Is Ondine Biomedical's OCF Margin % too high?
Ondine Biomedical's current OCF Margin % is -837.19%. Based on the distribution chart, Ondine Biomedical ranks #753 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Ondine Biomedical has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ondine Biomedical ranks #753 out of 950 companies for OCF Margin %. This places Ondine Biomedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current OCF Margin % is -837.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Ondine Biomedical (FRA:VF5) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.09, compared to a current price of €0.15 — trading 66.7% above its estimated fair value. The current OCF Margin % is -837.19%. Ondine Biomedical's overall GF Score™ is 37/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current OCF Margin % is -837.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ondine Biomedical (FRA:VF5) Overvalued in 2026?

Based on GuruFocus' analysis, Ondine Biomedical stock appears to be overvalued. The current stock price of €0.15 is trading 66.7% above its estimated GF Value™ of €0.09. GuruFocus considers Ondine Biomedical to be Significantly Overvalued.

Key valuation signals for FRA:VF5:

  • OCF Margin %: -837.19%
  • GF Value™: €0.09 vs. price of €0.15 (66.7% above fair value)
  • GF Score™: 37/100 with 9 warning signs

No single metric tells the full story. See the FRA:VF5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ondine Biomedical Business Description

Other Exchanges OBIMF:USAOBI:UK
Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
37GF Score

Get the complete analysis for FRA:VF5

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price
€0.09
GF Value